Showing results (71-80 of 888) with videos related to
Sort By:
Pageof 89
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 18, 2001
Novel aspects of erythropoietin response in renal failure patientsG Sunder-Plassmann, W H HörlAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Effect of erythropoietin on cardiovascular diseasesG Sunder-Plassmann, W H HörlWiener Medizinische Wochenschrift (1946)|July 14, 2001
[Angiotensin II type-1-receptor antagonists from the viewpoint of nephrology]A C Hauser, W H HörlNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1995
Importance of iron supply for erythropoietin therapyG Sunder-Plassmann, W H HörlNew Horizons (Baltimore, Md.)|November 1, 1995
The immune system in uremia and during its treatmentM Haag-Weber, W H HörlSeminars in Nephrology|May 1, 1996
Dysfunction of polymorphonuclear leukocytes in uremiaM Haag-Weber, W H HörlNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1996
Are granulocyte inhibitory proteins contributing to enhanced susceptibility to infections in uraemia?M Haag-Weber, W H HörlSouthern Medical Journal|January 7, 2000
Zinc protoporphyrin and percentage of hypochromic erythrocytes as markers of functional iron deficiency during therapy with erythropoietin in patients with advanced acquired immunodeficiency syndromeF K Matzkies, P Cullen, L Schaefer, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 1996
Safety of intravenous injection of iron saccharate in haemodialysis patientsG Sunder-Plassmann, W H HörlPageof 89